NO751939L - - Google Patents

Info

Publication number
NO751939L
NO751939L NO751939A NO751939A NO751939L NO 751939 L NO751939 L NO 751939L NO 751939 A NO751939 A NO 751939A NO 751939 A NO751939 A NO 751939A NO 751939 L NO751939 L NO 751939L
Authority
NO
Norway
Prior art keywords
stated
hydrogen
fluorination
fluorinating agent
hydroxy
Prior art date
Application number
NO751939A
Other languages
English (en)
Norwegian (no)
Inventor
D H R Barton
R H Hesse
Original Assignee
Res Inst Medicine Chem
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Res Inst Medicine Chem filed Critical Res Inst Medicine Chem
Publication of NO751939L publication Critical patent/NO751939L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B39/00—Halogenation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C17/00—Preparation of halogenated hydrocarbons
    • C07C17/093—Preparation of halogenated hydrocarbons by replacement by halogens
    • C07C17/10—Preparation of halogenated hydrocarbons by replacement by halogens of hydrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0011—Androstane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C07J1/0025—Esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of only two carbon atoms, e.g. pregnane derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
    • C07J7/002—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/004—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
    • C07J7/005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa substituted in position 16
    • C07J7/0055—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO751939A 1974-06-04 1975-06-03 NO751939L (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB24734/74A GB1513135A (en) 1974-06-04 1974-06-04 Fluorination process and fluoro steroids

Publications (1)

Publication Number Publication Date
NO751939L true NO751939L (fr) 1975-12-05

Family

ID=10216416

Family Applications (1)

Application Number Title Priority Date Filing Date
NO751939A NO751939L (fr) 1974-06-04 1975-06-03

Country Status (21)

Country Link
US (2) US4036864A (fr)
JP (1) JPS514102A (fr)
AU (1) AU498203B2 (fr)
BE (1) BE829809A (fr)
CA (1) CA1064475A (fr)
CH (1) CH616397A5 (fr)
DE (1) DE2524618A1 (fr)
DK (1) DK248075A (fr)
ES (1) ES438166A1 (fr)
FR (1) FR2275426A1 (fr)
GB (1) GB1513135A (fr)
IE (1) IE41545B1 (fr)
IL (1) IL47418A (fr)
IN (1) IN142193B (fr)
IT (1) IT1035927B (fr)
LU (1) LU72637A1 (fr)
NL (1) NL7506547A (fr)
NO (1) NO751939L (fr)
NZ (1) NZ177688A (fr)
SE (1) SE7506339L (fr)
ZA (1) ZA753588B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1513135A (en) * 1974-06-04 1978-06-07 Res Inst For Med & Chem Inc Fluorination process and fluoro steroids
US5116599A (en) * 1989-07-31 1992-05-26 Johns Hopkins Univ. Perfluoro-t-butyl-containing compounds for use in fluorine-19 nmr and/or mri
US5234680A (en) * 1989-07-31 1993-08-10 Johns Hopkins Univ. Perfluoro-t-butyl-containing compounds for use in fluorine-19 NMR and/or MRI
ES2175614T3 (es) * 1997-04-10 2002-11-16 Pfizer Derivados fluorosustituidos de adamantano.
DE19738196A1 (de) * 1997-09-02 1999-03-04 Hoechst Ag Verfahren zur Herstellung von Fluor enthaltenden Verbindungen in hoher Reinheit
US6673262B1 (en) * 1997-12-18 2004-01-06 Central Glass Company, Limited Gas for removing deposit and removal method using same
GB9924705D0 (en) * 1999-10-20 1999-12-22 F2 Chemicals Ltd Preparation of selectively fluorinated organic compounds
US6455728B1 (en) * 1999-11-01 2002-09-24 Air Products And Chemicals, Inc. Direct fluorination process for preparing high purity 2-fluoro-1,3-dicarbonyl compounds using oxygen as a radical scavenger
AU2003289036A1 (en) * 2002-12-11 2004-06-30 Asahi Glass Company, Limited Fluorinated adamantane derivatives
US7488847B2 (en) 2002-12-11 2009-02-10 Asahi Glass Company, Limited Fluorinated adamantane and its derivatives
WO2005123650A1 (fr) * 2004-06-16 2005-12-29 Asahi Glass Company, Limited Nouveau d)riv) d'adamantane fluor)
EP1757575A4 (fr) 2004-06-16 2008-05-07 Asahi Glass Co Ltd Dérivé de fluoroadamantane
US20080275112A1 (en) * 2004-07-23 2008-11-06 Schreiner Peter R Invention Concerning Aminoadamantane Compounds
EP2053055A1 (fr) * 2007-10-24 2009-04-29 Bayer Schering Pharma Aktiengesellschaft 11.beta.-fluoro-3-acetoxyestra-3,5-dien-17-one et son procédé de fabrication
CN112979409B (zh) * 2019-12-13 2022-09-30 浙江省化工研究院有限公司 一种气相催化氯化制备3,3,3-三氯-1,1,1-三氟丙烷的方法
CN116003372A (zh) * 2022-09-14 2023-04-25 多氟多新材料股份有限公司 一种氟代碳酸乙烯酯的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1599766A (fr) * 1967-09-11 1970-07-20
GB1513135A (en) * 1974-06-04 1978-06-07 Res Inst For Med & Chem Inc Fluorination process and fluoro steroids

Also Published As

Publication number Publication date
GB1513135A (en) 1978-06-07
US4036864A (en) 1977-07-19
AU8179575A (en) 1976-12-09
FR2275426A1 (fr) 1976-01-16
BE829809A (fr) 1975-12-03
FR2275426B1 (fr) 1979-07-13
DE2524618A1 (de) 1976-01-02
ES438166A1 (es) 1977-02-01
IL47418A (en) 1979-11-30
NL7506547A (nl) 1975-12-08
SE7506339L (sv) 1975-12-05
IT1035927B (it) 1979-10-20
US4284558A (en) 1981-08-18
ZA753588B (en) 1976-05-26
DK248075A (da) 1975-12-05
JPS514102A (fr) 1976-01-14
IN142193B (fr) 1977-06-11
CH616397A5 (fr) 1980-03-31
AU498203B2 (en) 1979-02-22
IE41545B1 (en) 1980-01-30
IL47418A0 (en) 1975-08-31
IE41545L (en) 1975-12-04
NZ177688A (en) 1978-03-06
CA1064475A (fr) 1979-10-16
LU72637A1 (fr) 1976-03-17

Similar Documents

Publication Publication Date Title
NO751939L (fr)
US6111118A (en) Process for effecting allylic oxidation
US4022891A (en) Novel 1α,24-dihydroxycholecalciferol compositions, novel precursors thereof, and processes for preparing them
EP2632896B1 (fr) Réactifs électrophiles pour monohalométhylation, leur préparation et leurs utilisations
CZ292860B6 (cs) Deriváty androstenu a farmaceutický prostředek obsahující tyto deriváty
EP0073026B1 (fr) 17,17 bis (thio substitué)-3-céto androstènes et compositions pharmaceutiques
WO2007054974A2 (fr) Procede de chimie verte pour la preparation d’esters de pregnadiene
KR100312269B1 (ko) 6알파,9알파-디플루오르화스테로이드의신규제조방법및중간체
AU775831B2 (en) Process for preparing 17alpha-acetoxy-11beta-(4-N,N-(dimethylamino)phenyl)-21- methoxy-19-norpregna-4,9-diene-3,20-dione, intermediates useful in the process, and processes for preparing such intermediates
Boswell Jr Reaction of nitrosyl fluoride and selected steroid enes. New synthesis of. DELTA. 5-4-keto steroids
NO165679B (no) Analogifremgangsmaate for fremstilling av nye, terapeutiskvirksomme androstan-17beta-karboksyl-syreestere.
CA1101410A (fr) Traduction non-disponible
Marwah et al. Steroidal allylic fluorination using diethylaminosulfur trifluoride: A convenient method for the synthesis of 3β-acetoxy-7α-and 7β-fluoroandrost-5-en-17-one
WO1988009337A1 (fr) Chloration selective de steroides et d'autres substrats dirigee par des agents lies par covalence comprenant une combinaison cyclique contenant de l'azote et servant de modeles
EP2576584A1 (fr) Procédés et composés pour préparer des composés organiques monofluorométhylés biologiquement actifs
JPS6244560B2 (fr)
US6686486B1 (en) Process for effecting allylic oxidation
RU2099346C1 (ru) Стероиды, способ получения стероидов, способ получения 16-метиленстероидов, соединения
JPH07506120A (ja) フッ素化４−アミノアンドロスタジエノン誘導体及びその製造方法
JPS63280094A (ja) ３−メチレン−４−アンドロステン−１７−オン、その製造法、および該化合物を含有する、エストロゲン生合成阻止作用および受胎能変更作用を有する医薬
KR790001663B1 (ko) 포화유기화합물의 친전자성 불소치환법
US4252719A (en) Steroid conversion method and products produced thereby
US3641005A (en) Process for the preparation of delta**4-6 6-difluoro - 320 - diketo - 17alp ha21-dihydr-oxypregnenes
US4064148A (en) Chemical process for preparing Δ9(11) dehydrosteroids
JPS59144800A (ja) アンドロステン−１７−ジチオケタ−ル類